STOCK TITAN

DelphX Provides Operational Update for Industry-First CRS Product; Launch Terms in Final Stage

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
DelphX Capital Markets provides operational update on the launch of their novel Credit Rating Security (CRS) product. The company has completed all document approvals and pre-launch requirements and is currently working with two Qualified Institutional Buyers (QIBs) to negotiate the terms and conditions of the first commercial transaction. DelphX plans to complete this transaction in early Q4 2023 and is in late-stage discussions with hedge funds and dealers for wider adoption of the CRS product.
Positive
  • DelphX has completed all document approvals and pre-launch requirements for their CRS product
  • Working with two QIBs to negotiate terms of first commercial transaction
  • In late-stage discussions with hedge funds and dealers for wider adoption of CRS product
Negative
  • None.

Toronto, Ontario--(Newsfile Corp. - October 17, 2023) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products for the fixed income market, is providing an operational update in advance of significant launch-related milestones scheduled for the remainder of 2023.

As previously reported, outside counsel had completed the main documentation required for the launch of the Company's novel Credit Rating Security (CRS) product, which will give bond holders and traders the ability to position against potential rating changes on existing bonds. This will be the first product of its kind in the structured products market. DelphX has now completed all document approvals and pre-launch requirements with its custodian and other service providers. The Company is currently working with two Qualified Institutional Buyers (QIBs) to negotiate the terms and conditions of the first commercial transaction.

This first transaction was rescheduled by a few weeks in order to complete some additional requirements from partner organizations, to select an underlying bond and negotiate pricing which is representative of target portfolio holders. The company's wholly-owned broker dealer is acting as placement agent for this first transaction, which also includes the onboarding of the two QIBs. DelphX plans to complete this first transaction in early Q4 2023, with additional announcements expected on a consistent basis as other pending transactions and partnerships develop through the remainder of the year and into 2024. In addition to the two QIBs participating in the Company's inaugural transaction, DelphX is pleased to report that it is in late-stage discussions with large hedge funds and dealers regarding adoption and strategic alignment of the Company's industry-first CRS product on a larger scale. The focus has been on continuous adoption and use of the CRS product as transactions begin.

Bond default and downgrade cycles go hand in hand, and all of the major rating agencies have raised their expectations for a rising default/downgrade cycle into 2024, with higher-than-average default rates through at least the next 12-15 months. Under this scenario, according to Fitch, peak default rates are expected to rise from less than 3% to 4.5-6.5% in 2024. Extending out even further, Moody's recently posted data showing that high-yield debt issuers have a record $1.87 trillion of debt maturing in the period running from 2024 to 2028, up 27% from a similar study last year. Of particular importance for DelphX, the single B category accounts for 62% of total maturities during this time frame, according to Moody's, putting the bulk of upcoming refinancing risk (and potential downgrades) directly in the Company's CRS target market.

CEO Commentary

"The timing of our CRS solution is perfectly aligned with emerging multi-year trends in the debt markets," explained DelphX CEO Patrick Wood. "The next couple of years are going to provide tremendous opportunities on both sides of the CRS trade - offering protection for the more vulnerable parts of a portfolio manager's holdings, while also giving more speculative investors the opportunity to significantly boost returns. Defaults are relatively rare, but downgrades are common, particularly during the kind of economic conditions predicted by the major rating agencies."

"There doesn't seem to be a topic without heated debate in the fixed income market right now, with very wide opinion on the trajectory of rates, soft vs hard landing, government spending, and a host of other factors combining to create heightened volatility. With the completion of our first CRS trade, we will be handing the industry a new way to turn these opinions into actionable transactions in areas not previously available. Our launch will showcase a major change in the way that managers can reduce risk or stretch for above average yield, creating trading desk opportunities for these two major goals of fixed income investors. We are inviting all institutional holders of bond portfolios and opportunistic traders to test our product to see firsthand the benefits of our CRS solution. We will be back with additional updates in the near future as our launch program commences."

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that optimally transfer and diffuse credit risk, while allowing the enhancement of returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

  • Collateralized put options (CPOs) that provide rating change protection for underlying corporate bonds;
  • Collateralized reference notes (CRNs) that enable hedge funds and others to take on rating downgrade exposure of an underlying corporate bond in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com.

Mark Forney, Corporate Development
DelphX Capital Markets Inc.
mark.forney@delphx.com
(718) 509-2160

Forward-Looking Statements

This news release contains certain "forward-looking statements" including, without limitation, statements regarding the launch of the DelphX platform. Such forward-looking statements involve risks and uncertainties, both known and unknown, that may cause actual results or events to be materially different from those expressed or implied by such forward-looking statements, including but not limited to, business, economic and capital market conditions, regulatory uncertainties, and the demand for our products. The forward-looking statements in this news release are based on factors and assumptions regarding, among other things, the state of the capital markets, the ability of DelphX to successfully manage the risks inherent in pursuing business opportunities in the financial services industry, and the ability of DelphX to obtain qualified staff, equipment and services in a timely and cost-efficient manner to develop its business. Any forward-looking statement reflects information available to DelphX as of the date of this news release and, except as may be required by applicable laws, DelphX undertakes no intent or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or results or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/184196

FAQ

What is DelphX's CRS product?

DelphX's CRS product is a novel Credit Rating Security that allows bond holders and traders to position against potential rating changes on existing bonds.

When will DelphX complete their first commercial transaction?

DelphX plans to complete their first commercial transaction in early Q4 2023.

Who is DelphX working with for wider adoption of their CRS product?

DelphX is in late-stage discussions with hedge funds and dealers for wider adoption of their CRS product.

DELPHX CAP MKTS INC

OTC:DPXCF

DPXCF Rankings

DPXCF Latest News

DPXCF Stock Data

15.50M
123.85M
31.83%
14.74%
Capital Markets
Financial Services
Link
United States of America
Toronto